CClinicalTrials.gg
RecruitingNCT07217756Updated Oct 20, 2025

Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study

An observational study in Obesity & Overweight and Orthodontic Treatment, sponsored by University of Rochester. Recruiting at 1 site in United States. Open to participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-20.

Sponsored by University of Rochester · Observational

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 5 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
52
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The goal of this prospective observational study is to assess the influence of increased body mass index (BMI) on various oral health and orthodontic-related parameters in adolescents undergoing orthodontic therapy (OT) with braces. These parameters include gum inflammation, tooth decalcifications/discolorations, tooth alignment of lower incisors, and various inflammatory and microbiological parameters in the collected saliva and gum fluid of the patients. The primary purpose is to assess if an increased BMI is a risk factor for oral inflammation in adolescents undergoing OT. The main questions it aims to answer are:

  1. Do patients with an increased BMI undergoing OT demonstrate increased microbial counts in the saliva compared to patients with normal BMI?
  2. Do patients with increased BMI undergoing OT demonstrate increased gum inflammation, tooth discolorations, and higher levels of inflammatory markers in the saliva and gum fluid samples compared to patients with normal BMI? This study will include 2 study groups (patients with increased BMI-test group, and normal weight patients-control group). The participants will be asked to complete a study questionnaire, which will collect information regarding their demographics, their family socioeconomic and educational status, dietary habits, and oral health-related quality of life. The participants will also receive an oral examination (evaluation of their gum health), and they will have their intraoral photos taken, as well as an impression of their lower teeth (to create dental models). A saliva sample will be obtained by asking patients to passively "drool" in a tube, and a gingival fluid sample will be collected from the gums of the lower anterior teeth using thin paper strips. All these study procedures will be conducted at baseline (T1: before bonding of braces), and at an approximately 6-month follow-up visit (T2). Comparisons of these outcomes will be conducted between the two groups and across timepoints.
02

Conditions studied

  • Obesity & Overweight
  • Orthodontic Treatment

Keywords

  • body mass index
  • obesity
  • orthodontic treatment
  • adolescents
  • fixed orthodontic appliances
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's planned enrollment of 52 is below the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adolescent patients undergoing fixed orthodontic therapy at the Eastman Institute for Oral Health, University of Rochester, NY.

Inclusion criteria

  • adolescents (12-17 years old);
  • patients scheduled to undergo comprehensive fixed orthodontic therapy (OT) (for at least 6 months with metal braces/wires) on both dental arches;
  • patients with increased BMI (≥25.0 Kg/m2) (test-Group);
  • patients with normal BMI [18.5-24.99 (Kg/m2)] (control-Group);
  • patients with all 6 mandibular anterior teeth present and mild-to-moderate mandibular crowding (\<7.5 mm);
  • patients and parents/guardians willing to provide signed assent/permission.

Exclusion criteria

Exclusion Criteria:

  • self-reported habitual tobacco product users;
  • patients with self-reported medical diseases such as hepatic diseases, blood disorders, cardiovascular diseases, HIV, diabetes mellitus, and viral infections;
  • patients with craniofacial syndromes and/or cleft lip and palate;
  • pregnant and/or lactating females (by self/parent report);
  • edentulous individuals;
  • patients with active or a history of periodontitis;
  • patients having undergone surgical and/or non-surgical periodontal therapy within the past 6 months;
  • patients with physical and/or mental/cognitive disabilities who are decisionally-impaired and not able to consent/assent for themselves;
  • patients who reported use of medications such as antibiotics, steroids (inhalers and/or pills), non-steroidal anti-inflammatory drugs, and antimicrobial mouth-rinses within the past 3 months or those who require prophylactic antibiotics prior to dental procedures;
  • patients undergoing cancer therapy;
  • underweight patients (BMI less than 18.5 Kg/m2);
  • patients with oral mucosal lesions such as median rhomboid glossitis and lichen planus;
  • patients with clinically visible carious teeth.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
52 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Increased BMI group (test group)

    The increased BMI group will include patients with a BMI\>25.0 Kg/m2.

  • Normal BMI group (control groups)

    The normal-BMI group will include patients with a BMI between 18.5 and 24.99 (Kg/m2).

06

What researchers measure

Primary outcomes

  1. Mean Change in Full-Mouth Bleeding Score (FMBS)

    Bleeding on probing (BOP) will be assessed dichotomously (yes/no) at six sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual/palatal, mid-lingual/palatal, and disto-lingual/palatal) using a standardized periodontal probe by trained examiners. The full-mouth bleeding score (FMBS) will be calculated as the percentage of sites that bleed out of the total number of sites examined. Higher percentages indicate greater gingival inflammation.

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

  2. Mean Change in White Spot Lesion (WSL) Score (International Caries Detection and Assessment System (ICDAS))

    Standardized intraoral and facial photographs will be taken using calibrated camera settings and stored in Dolphin Imaging Software. Each visible tooth surface will be examined for color, texture, and cavitation changes and scored using the International Caries Detection and Assessment System (ICDAS). Code 0 = sound surface; code 2 = visible white spot lesion; codes 3-4 = localized enamel breakdown or dentin shadowing; codes 5-6 = cavitated lesions extending into dentin. Because photos are obtained without air drying, code 1 will be excluded. The average WSL score per participant will be calculated by dividing the total ICDAS score by the number of surfaces assessed. Mean change = score at T2 minus score at T1. Higher scores indicate greater enamel decalcification.

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

  3. Mean Change in Salivary Microbial Counts of Candida albicans and Streptococcus mutans

    Unstimulated whole saliva will be collected at baseline and follow-up. C. albicans will be cultured on CHROMagar™ Candida and confirmed via germ tube test from three colonies per sample. S. mutans will be cultured on Mitis Salivarius Bacitracin medium and identified by colony morphology. DNA-based microbial identification and oral microbiome sequencing with bioinformatics analysis will also be performed. Microbial counts will be reported per participant as colony-forming units per milliliter (CFU/mL) or relative abundance. Higher values indicate greater microbial load.

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

Secondary outcomes

  1. Mean Change in Body Mass Index (BMI)

    Height (cm) will be measured using a stadiometer, and weight (kg) with a calibrated digital scale. BMI will be calculated as weight (kg)/height² (m²). Measurements will be taken twice and averaged. Higher BMI indicates greater body mass relative to height.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  2. Mean Change in Full-Mouth Plaque Score (FMPS)

    Plaque presence will be recorded on four surfaces per tooth (mesial, distal, buccal, lingual/palatal). The FMPS will be calculated as the percentage of surfaces with plaque present out of total surfaces examined. Higher percentages indicate poorer oral hygiene.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  3. Mean Change in Percentage of Sites with Probing Depth >3 mm

    Probing depth (PD) will be measured at six sites per tooth using a periodontal probe. The percentage of sites with PD greater than 3 mm will be calculated for each participant. Higher percentages indicate more severe periodontal disease.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  4. Mean Change in Oral Dryness Score (Challacombe Scale)

    Oral dryness will be assessed using the Challacombe Scale, which rates 10 indicators of xerostomia (e.g., lack of saliva pooling, frothy saliva, depapillation, fissured tongue). Scores range from 1 to 10, with 1-3 indicating mild dryness, 4-6 moderate, and 7-10 severe. Higher scores indicate greater dryness.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  5. Mean Change in Little's Irregularity Index (Tooth Alignment)

    Dental casts made from alginate impressions will be analyzed using a digital caliper (accuracy 0.01 mm). The sum of the linear displacements between the anatomic contact points of the mandibular incisors (five measurements) yields Little's Irregularity Index. Higher values indicate greater misalignment.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  6. Mean Change in Salivary Proinflammatory Biomarker Concentrations (IL-1β, IL-6, TNF-α, Leptin, Resistin)

    Salivary and gingival crevicular fluid samples will be centrifuged and analyzed using multiplexed magnetic bead assays (Milliplex MAP). Concentrations will be calculated from standard curves. Higher levels indicate greater inflammatory activity.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  7. Mean Change in Dietary Habits Score

    Participants will complete a standardized questionnaire assessing dietary habits related to oral health and obesity. Responses will be scored to produce a composite dietary habits score; higher scores indicate less healthy dietary patterns.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

  8. Mean Change in Oral Health-Related Quality of Life (OHIP-14 Total Score)

    The Oral Health Impact Profile-14 (OHIP-14) questionnaire will assess functional limitation, pain, and psychological and social impacts of oral health. Scores from 14 items are summed (range 0-56); higher scores indicate poorer oral health-related quality of life.

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

07

Study locations

1 of 1 sites recruiting
  • Eastman Institute for Oral Health, University of Rochester
    Rochester, New York 14620, United States
    • Dimitrios Michelogiannakis, DDS, MS · Contact · Dimitrios_Michelogiannakis@URMC.Rochester.edu · 585-275-5012
    • Dimitrios Michelogiannakis, DDS, MS · Principal investigator
    • Elli Anna Kotsailidi, DDS, MS · Sub investigator
    • Paul Emile Rossouw, DDS, PhD · Sub investigator
    • Luis Mendez, DDS · Sub investigator
    • Ibrahim Kassem, DDS, MS · Sub investigator
    • Atoosa Pahlavani, DDS, MS · Sub investigator
    • Jin Xiao, DDS, PhD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to privacy concerns and the risk of re-identification, even with de-identified datasets. Additionally, the scope of consent obtained from participants during the trial does not include provisions for public sharing of individual-level data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07217756
Lead sponsor
University of Rochester
Collaborators
American Association of Orthodontists Foundation
Responsible party
Dimitrios Michelogiannakis (Associate Professor, Program Director of the Orthodontics Department, University of Rochester) — Principal investigator
First posted
Oct 16, 2025
Start date
Apr 22, 2022
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Oct 20, 2025

Study contacts

Dimitrios Michelogiannakis, DDS, MS
Contact
Dimitrios_Michelogiannakis@URMC.Rochester.edu
585-275-5012
Dimitrios Michelogiannakis, DDS, MS
principal investigator · Eastman Institute for Oral Health, University of Rochester

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion